시장보고서 | 연간정보서비스 | 맞춤형시장조사 | 메일링 | 샘플 요청 목록
세계의 전자 임상 결과 평가 솔루션 시장 보고서(2025년)
Electronic Clinical Outcome Assessment Solutions Global Market Report 2025
상품코드 : 1824525
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ￦ 6,516,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ￦ 9,419,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ￦ 12,322,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

전자 임상 결과 평가 솔루션 시장 규모는 향후 몇 년 동안 급성장할 것으로 예상됩니다. 2029년에는 32억 2,000만 달러로 성장할 것이며, 13.6%의 연평균 성장률을 보일 것입니다. 예측 기간의 성장 요인으로는 웨어러블 기기와의 통합, 분산형 및 하이브리드 임상 검사, 환자 참여 전략, 보안 및 컴플라이언스 대책, 원격 모니터링, 임상시험 기관과의 연계 등을 꼽았습니다. 예측 기간의 주요 동향으로는 인공지능, 임상 검사의 디지털화, 모바일 기술의 발전, 실제 증거의 통합, 환자 보고 결과(PRO)의 중요성 등을 꼽을 수 있습니다.

향후 5년간 13.6%의 성장률 전망은 지난번 전망치보다 0.2% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 무역 마찰은 캐나다와 영국에서 개발된 eCOA 플랫폼과 태블릿형 환자 보고 결과 시스템의 비용을 팽창시키고, 임상 검사 관리 비용을 증가시켜 임상 검사 효율화를 저해할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.

전자 임상 결과 평가 솔루션 시장은 연구개발 활동의 활성화로 인해 성장이 예상됩니다. 연구개발 활동에는 기업이 새로운 제품과 서비스를 혁신하고 도입하기 위한 노력이 포함됩니다. 전자 임상 결과 평가 솔루션은 임상 검사 결과 데이터를 전자적으로 획득함으로써 이러한 노력에 기여하고 있습니다. 일례로, 2023년 11월 미국 정부 기관인 National Center for Science and Engineering Statistics(국립과학기술통계센터)는 2022 회계연도에 학술기관이 조사개발에 투자한 총액은 978억 달러로 2021 회계연도에 비해 80억 달러 증가했다고 보고했습니다. 회계연도 대비 80억 달러 증가했다고 보고했습니다. 또한, 대학의 연구개발(R&D)을 위한 내부 자금은 2021 회계연도에 비해 21억 달러의 눈에 띄는 증가를 보였으며, 기업에서 대학으로의 R&D 자금은 5억 8,700만 달러의 증가를 보였습니다. 그 결과, R&D 활동의 급증은 전자 임상 결과 평가 솔루션 시장의 주요 촉진요인으로 작용하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 전략

제36장 부록

KSM
영문 목차

영문목차

Electronic clinical outcome assessment involves capturing outcome data electronically in clinical trials, streamlining the collection of crucial data points for analysis.

The primary categories of products within electronic clinical outcome assessment (eCOA) solutions include web-based eCOA solutions, on-premise-based eCOA solutions, and cloud-platform-based eCOA solutions. Web-based eCOA solutions denote programs distributed over a network, commonly a corporate intranet or the internet, and accessible through a standard web browser. These solutions encompass various approaches such as patient-reported outcome (PRO), clinician-reported outcome (ClinRO), observer-reported outcome (ObsRO), and performance outcome (PerfO). They find application in hospitals or healthcare providers, contract research organizations (CROs), pharmaceutical and biotechnology firms, medical device companies, and other end users.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The electronic clinical outcome assessment solutions market research report is one of a series of new reports from The Business Research Company that provides electronic clinical outcome assessment solutions market statistics, including electronic clinical outcome assessment solutions industry global market size, regional shares, competitors with an electronic clinical outcome assessment solutions market share, detailed electronic clinical outcome assessment solutions market segments, market trends and opportunities, and any further data you may need to thrive in the electronic clinical outcome assessment solutions industry. This electronic clinical outcome assessment solutions market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The electronic clinical outcome assessment solutions market size has grown rapidly in recent years. It will grow from $1.68 billion in 2024 to $1.94 billion in 2025 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to regulatory support, patient-centric approach, data quality and accuracy, cost efficiency and time savings, increasing global clinical trials.

The electronic clinical outcome assessment solutions market size is expected to see rapid growth in the next few years. It will grow to $3.22 billion in 2029 at a compound annual growth rate (CAGR) of 13.6%. The growth in the forecast period can be attributed to integration with wearable devices, decentralized and hybrid trials, patient engagement strategies, security and compliance measures, remote monitoring and site collaboration. Major trends in the forecast period include artificial intelligence in clinical trials, clinical trial digitization, advancements in mobile technology, real-world evidence integration, patient-reported outcomes (PROs) emphasis.

The forecast of 13.6% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions may hinder clinical trial efficiency by inflating costs for eCOA platforms and tablet-based patient-reported outcome systems developed in Canada and the UK, increasing trial management expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The electronic clinical outcome assessment solutions market is anticipated to experience growth due to an upswing in research and development activities. Research and development activities encompass the initiatives undertaken by companies to innovate and introduce new products and services. Electronic clinical outcome assessment solutions contribute to these endeavors by electronically capturing outcomes data in clinical trials. As an illustration, in November 2023, the National Center for Science and Engineering Statistics, a US-based government agency, reported that in the fiscal year 2022, academic institutions allocated a total of $97.8 billion to research and development, indicating an increase of $8.0 billion compared to fiscal year 2021. Furthermore, internal funding for Research and Development (R&D) at universities exhibited a notable rise of $2.1 billion compared to the fiscal year 2021, while R&D funding from businesses to universities saw a growth of $587 million. Consequently, the surge in research and development activities is a key driver for the electronic clinical outcome assessment solutions market.

The anticipated growth of the electronic clinical outcome assessment solutions market is attributed to the rising number of clinical trials. Clinical trials are research studies or investigations conducted on human subjects to assess the safety, efficacy, and potential side effects of medical treatments, drugs, devices, or interventions. Electronic Clinical Outcome Assessment (eCOA) solutions play a vital role in clinical trials by offering a digital and streamlined approach to collecting patient-reported outcomes and other relevant data. For instance, as reported by the US-based digital media company Xtalks in May 2023, the global registration count on ClinicalTrials.gov reached 452,604 clinical trials in 2023, marking a significant increase from the reported over 365,000 registered trials in 2021. Furthermore, among these 452,604 clinical trials, 64,838 are actively recruiting participants. Hence, the escalating number of clinical trials serves as a catalyst for the growth of the electronic clinical outcome assessment solutions market.

Technological advancements are a significant trend gaining traction in the electronic clinical outcome assessment solutions market. Major companies in this sector are focused on developing innovative platforms to strengthen their market position. For example, in May 2024, EDETEK, a U.S.-based technology company specializing in digital solutions for the clinical trial sector, announced the launch of CONFORM eClinical Version 5.1. This comprehensive platform is designed to enhance and streamline clinical trial management processes. The new version integrates a wide array of components that facilitate efficient clinical research, addressing the evolving needs of sponsors and stakeholders within the pharmaceutical industry.

Key players in the electronic clinical outcome assessment solutions market are focusing their efforts on the development of innovative solutions, notably eCOA toolkits. An eCOA (Electronic Clinical Outcome Assessment) toolkit is a collection of software tools and resources strategically designed to facilitate the implementation and management of electronic methods for gathering patient-reported outcomes and other critical clinical trial data. As an illustration, in December 2022, Suvoda, a US-based software company, unveiled its electronic clinical outcome assessments (eCOA) design toolkit. This toolkit is seamlessly integrated with Suvoda IRT and eConsent, addressing previous shortcomings that have impacted the field of eCOA. It features a specialized language and authoring tool specifically crafted for the creation of eCOA questionnaires.

In November 2022, Citeline, a leading provider of pharmaceutical intelligence solutions based in the U.S., merged with Norstella in a deal valued at approximately $5 billion. This merger aims to enhance patient outcomes by improving access to therapies, streamlining drug development processes, and providing innovative solutions tailored to the evolving needs of the pharmaceutical industry. Norstella is recognized as a global leader in pharmaceutical intelligence and consulting services, also based in the U.S.

Major companies operating in the electronic clinical outcome assessment solutions market include IQVIA Holdings Inc., Oracle Corporation, ERT Clinical, Dassault Systemes SE, OmniComm Systems Inc., Parexel International Corporation, Veeva Systems Inc., KUKDO CHEMICAL CO. LTD., Medidata Solutions Inc., Signant Health, Clario Inc., ArisGlobal LLC, Merge Healthcare Inc., YPrime LLC, eClinical Solutions LLC, CRF Bracket Company, Anju Software Inc., Castor EDC B.V., Kayentis, Mednet Solutions LLC, Clinical Ink Inc., Cloudbyz Inc., Climedo Health GmbH, ClinCapture Inc.

North America was the largest region in the electronic clinical outcome assessment solutions market in 2024. Asia-Pacific is expected to be the fastest-growing region in the electronic clinical outcome assessment solutions market during the forecast period. The regions covered in the electronic clinical outcome assessment solutions market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the electronic clinical outcome assessment solutions market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The electronic clinical outcome assessment solutions market consists of sales of eCOA live, eCOA multimedia, eCOA rescue studies, and suicidal ideation. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Electronic Clinical Outcome Assessment Solutions Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on electronic clinical outcome assessment solutions market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for electronic clinical outcome assessment solutions ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The electronic clinical outcome assessment solutions market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Electronic Clinical Outcome Assessment Solutions Market Characteristics

3. Electronic Clinical Outcome Assessment Solutions Market Trends And Strategies

4. Electronic Clinical Outcome Assessment Solutions Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Electronic Clinical Outcome Assessment Solutions Growth Analysis And Strategic Analysis Framework

6. Electronic Clinical Outcome Assessment Solutions Market Segmentation

7. Electronic Clinical Outcome Assessment Solutions Market Regional And Country Analysis

8. Asia-Pacific Electronic Clinical Outcome Assessment Solutions Market

9. China Electronic Clinical Outcome Assessment Solutions Market

10. India Electronic Clinical Outcome Assessment Solutions Market

11. Japan Electronic Clinical Outcome Assessment Solutions Market

12. Australia Electronic Clinical Outcome Assessment Solutions Market

13. Indonesia Electronic Clinical Outcome Assessment Solutions Market

14. South Korea Electronic Clinical Outcome Assessment Solutions Market

15. Western Europe Electronic Clinical Outcome Assessment Solutions Market

16. UK Electronic Clinical Outcome Assessment Solutions Market

17. Germany Electronic Clinical Outcome Assessment Solutions Market

18. France Electronic Clinical Outcome Assessment Solutions Market

19. Italy Electronic Clinical Outcome Assessment Solutions Market

20. Spain Electronic Clinical Outcome Assessment Solutions Market

21. Eastern Europe Electronic Clinical Outcome Assessment Solutions Market

22. Russia Electronic Clinical Outcome Assessment Solutions Market

23. North America Electronic Clinical Outcome Assessment Solutions Market

24. USA Electronic Clinical Outcome Assessment Solutions Market

25. Canada Electronic Clinical Outcome Assessment Solutions Market

26. South America Electronic Clinical Outcome Assessment Solutions Market

27. Brazil Electronic Clinical Outcome Assessment Solutions Market

28. Middle East Electronic Clinical Outcome Assessment Solutions Market

29. Africa Electronic Clinical Outcome Assessment Solutions Market

30. Electronic Clinical Outcome Assessment Solutions Market Competitive Landscape And Company Profiles

31. Electronic Clinical Outcome Assessment Solutions Market Other Major And Innovative Companies

32. Global Electronic Clinical Outcome Assessment Solutions Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Electronic Clinical Outcome Assessment Solutions Market

34. Recent Developments In The Electronic Clinical Outcome Assessment Solutions Market

35. Electronic Clinical Outcome Assessment Solutions Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기